A detailed history of Royal Bank Of Canada transactions in Nevro Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 4,665 shares of NVRO stock, worth $21,085. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,665
Previous 4,353 7.17%
Holding current value
$21,085
Previous $36,000 27.78%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.71 - $10.1 $1,469 - $3,151
312 Added 7.17%
4,665 $26,000
Q2 2024

Aug 14, 2024

BUY
$7.96 - $13.59 $19,279 - $32,914
2,422 Added 125.43%
4,353 $36,000
Q1 2024

Nov 05, 2024

SELL
$13.56 - $20.78 $32,842 - $50,329
-2,422 Reduced 55.64%
1,931 $27,000
Q1 2024

May 15, 2024

SELL
$13.56 - $20.78 $148,997 - $228,330
-10,988 Reduced 85.05%
1,931 $27,000
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $90,312 - $142,092
6,369 Added 97.24%
12,919 $278,000
Q3 2023

Nov 14, 2023

BUY
$18.22 - $25.85 $11,970 - $16,983
657 Added 11.15%
6,550 $125,000
Q2 2023

Aug 14, 2023

BUY
$22.62 - $39.32 $51,528 - $89,570
2,278 Added 63.02%
5,893 $149,000
Q1 2023

May 15, 2023

SELL
$30.17 - $41.11 $73,916 - $100,719
-2,450 Reduced 40.4%
3,615 $130,000
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $153,406 - $208,023
4,211 Added 227.13%
6,065 $240,000
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $6,830 - $8,909
168 Added 9.96%
1,854 $86,000
Q2 2022

Aug 15, 2022

SELL
$40.85 - $77.67 $78,268 - $148,815
-1,916 Reduced 53.19%
1,686 $75,000
Q1 2022

May 16, 2022

SELL
$59.95 - $92.06 $304,126 - $467,020
-5,073 Reduced 58.48%
3,602 $260,000
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $262,261 - $392,373
3,235 Added 59.47%
8,675 $703,000
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $1.7 Million - $2.77 Million
-16,657 Reduced 75.38%
5,440 $633,000
Q2 2021

Aug 16, 2021

BUY
$141.6 - $179.06 $3.13 Million - $3.96 Million
22,097 New
22,097 $3.66 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.